Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Document Indications for Psychotropic Medication Use

Roseville, California Survey Completed on 06-27-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that two residents were free from unnecessary drugs, including chemical restraints, by administering psychotropic medications without adequate documentation of specific target behaviors or appropriate indications for use. One resident with bipolar disorder and anxiety was prescribed aripiprazole and olanzapine for bipolar disorder, but the orders lacked detailed descriptions of the behaviors these medications were intended to address. The facility's Medication Regimen Review (MRR) questioned the appropriateness of these medications, noting that antipsychotics are not typically used for depression, especially when the manifestation is manic phases. During interviews, facility leadership acknowledged that the orders needed to specify behaviors to allow for accurate monitoring. Another resident with dementia was prescribed Depakote for behaviors manifested by dementia, but the order did not specify the particular behaviors being treated. The MRR repeatedly indicated that the documentation was insufficient to justify the use of Depakote. Facility staff confirmed that the recommendation to update the order with specific target behaviors was missed, partly due to the resident's hospitalization and subsequent hold on orders. The facility's policy requires that symptoms warranting psychotropic medication use be clearly identified, evaluated, and documented, which was not done in these cases.

An unhandled error has occurred. Reload 🗙